trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim
Fasting before blood tests is necessary to establish accurate baseline biomarker levels
the verdict
CONTESTED
the evidence cuts both ways
confidence 43/100

While fasting remains a standard recommendation for establishing reliable baselines for specific metabolic biomarkers like lipids and targeted therapies, recent evidence shows that nonfasting blood tests can also yield clinically valid measurements for many routine assessments.

The evidence we hold leans leans supported

How this was weighed

official record 3x · fact-check 2x · hedged 1x · crowd & reference 1x

  • Blood sphingolipidomics in healthy humans: impact of sample · peer-reviewed · supports · weight 2 · 2010
  • Postprandial serum phosphorus and calcium concentrations in · peer-reviewed · supports · weight 1.05 · 2026
  • Plasma Lipidomics of Preadolescent Children: A Hokkaido Stud · peer-reviewed · refutes · weight 1.05 · 2025
  • Postprandial serum phosphorus and calcium concentrations in · peer-reviewed · refutes · weight 1.05 · 2026
Evidence for · 2
Blood sphingolipidomics in healthy humans: impact of sample collection methodology
2010 · cited by 316
Demonstrates that certain blood lipid and sphingolipid components, such as C16-sphingomyelin, are significantly altered by fasting conditions.
Evidence against · 2
Plasma Lipidomics of Preadolescent Children: A Hokkaido Study.
2025 · cited by 2
Analyzes plasma lipidomes effectively in nonfasting preadolescent children to establish meaningful clinical biomarker intervals and associations.
See more details
More for · 1
Postprandial serum phosphorus and calcium concentrations in adults and children with X-linked hypophosphatemia during burosumab treatment.
2026 · cited by 1
Notes that standardized clinical monitoring protocols for specific treatments like burosumab traditionally recommend morning fasted states to minimize variance.
More against · 1
Postprandial serum phosphorus and calcium concentrations in adults and children with X-linked hypophosphatemia during burosumab treatment.
2026 · cited by 1
Finds no clinically meaningful difference in mean serum phosphorus and calcium levels after meals compared to fasted states, suggesting nonfasting testing is viable.
The paper trail · every fact has a biography
first checked02 Aug 2026
judged → CONTESTED · 4302 Aug 2026
This receipt carries no identity, shared or not. Sharing publishes your connection to it, not your data.
Check your own claim
Challenge the receipt
trust me, bro: win the argument, pass the class, survive peer review.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt